COVID-19 has introduced a new normal that drastically changed how the world goes round. At times like these, a vaccine is needed for our society to come back together — without the need to distance ourselves from one another.
- People are highly optimistic that the COVID-19 vaccine will work to combat the pandemic
- 45% of people think it’s important to know the vaccine’s origin before taking the shot.
- Vaccine cost matters and more people would likely take it if the expense is covered by their employer or their insurance provider.
All in order to end the pandemic, medical professionals from different laboratories around the world are rushing to formulate an effective vaccine that can protect the general public. Hence, the COVID-19 vaccine is currently the utmost solution for our society to hit the streets and go back to our usual way of life.
However, Real Research recognizes how public participation is essential to ensure the success of the COVID-19 vaccine within the community. As people should take the vaccine to be effective in curbing the coronavirus further spread and to cease its power over the human body. Real Research launched a global survey to more about public opinion about the COVID-19 vaccine.
Most of the respondents when asked if they actually know the science behind the COVID-19 vaccine answered yes (84%). Only about a few (16%) admit to not having a complete understanding of how vaccines work. Knowing this, we believe that the majority of our respondents are able to make sound decisions about the vaccine for themselves.
In terms of optimism about the efficiency of the vaccine, most people are hopeful that the vaccine will work. More than a quarter (37%) of respondents claim to be ‘highly optimistic’. It is followed by a not far behind percentage of respondents (36%) who are ‘somewhat optimistic’ for the vaccine.
However, no matter how the COVID-19 vaccine is positive news for all, there can be skeptics (26%) vaccines will curb the coronavirus. Comprising this number are respondents who answered ‘somewhat not optimistic’ (18%) and ‘not optimistic at all’ (9%).
Need for Transparency in Vaccine Distribution
Before taking the vaccine, how much information about the vaccine’s origin matters to people? Real Research aims to find out by asking respondents how important it is for them to know the manufacturer of the vaccine and limit the possible answers to four levels of importance with a description for each.
Almost half of the respondents demanded to know the vaccine’s manufacturer. This is clearly evident in the result of the survey where 44% of respondents state that it is very important for them to know the vaccine manufacturer, specifically to check whether the vaccine was developed by an authorized team from reputable laboratories.
Meanwhile, for others who answered ‘somewhat important’ (29%), knowing the vaccine’s originating country is enough. Those who responded ‘somewhat not important’ (18%) actually value their local health authorities’ approval and verification before taking the COVID-19 vaccine shot. At last, the minority that replied “not important” (9%) considers the manufacturer’s details as insignificant.
The COVID-19 Vaccine: The Price Tag Matters
The price matters but not entirely true for all. According to the results, people who said to only take the vaccine if it is affordable for them takes almost a quarter of the total respondents (32%). Though cost matters for some (24%) they would take the vaccine regardless of price as long as it’s from the government. However, the price-conscious respondents (25%) would only take the shot if the cost is covered by their employer or health insurance.
There are some who overlook the price tag as well. The people (12%) who focus on the main offering of the vaccine—protection of one’s health. Also, the ones who are ready to take a shot once it’s ready and available (8%) no matter the cost.
Are people ready to take the COVID-19 vaccine?
Real Research asked a direct question whether the people would take the COVID-19 vaccine once it’s released. They have various responses; most will do without hesitation, but for some others with conditions.
Based on the results, the majority (40%)would take the Vaccine shot immediately once it’s available. It is followed by those respondents who prefer to take the vaccine after 6 months of observation (36%). Some others are also not in a hurry and explain that they would only take the vaccine if it was required by the government of their employer (6%). And only a few stand with the decision not to take the COVID-19 vaccine once it’s ready and available.
This question is very important in observing the possible reaction of the public once an effective COVID-19 vaccine gets launched. The people’s willingness to take the vaccine added to the possible success rate to combat the pandemic brought about a novel coronavirus.
In conclusion, despite skepticism like possible questioning of where the vaccine came from, waiting for six months to observe side-effects, most of the people are willing to be vaccinated. Cooperation among individuals in this activity assures a better health resolution for the whole community.
Real Research conducted a global survey for 8000 respondents worldwide. We have analyzed the responses to understand people’s perception toward vaccines in general and specifically people’s reactions to the upcoming COVID-19 vaccine.